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Abstract
Background: The value of cardiac rehabilitation (CR) after a transient ischaemic attack (TIA) or minor stroke is untested
despite these conditions sharing similar pathology and risk factors to coronary heart disease. We aimed to evaluate the
feasibility of conducting a trial of an adapted home-based CR programme, ‘The Healthy Brain Rehabilitation Manual’,
for patients following a TIA/minor stroke, participants’ views on the intervention and, to identify the behaviour change
techniques (BCTs) used.
Methods: Clinicians were asked to identify patients attending the Ulster Hospital, Belfast within 4 weeks of a first TIA or
minor stroke. Those who agreed to participate underwent assessments of physical fitness, cardiovascular risk, quality of
life and mental health, before random allocation to: Group (1) standard/usual care; (2) rehabilitation manual or (3)
manual plus pedometer. All participants received telephone support at 1 and 4 weeks, reassessment at 6 weeks and an
invitation to a focus group exploring views regarding the study. Two trained review authors independently assessed
the manual to identify the BCTs used.
Results: Twenty-eight patients were invited to participate, with 15 (10 men, 5 women; 9 TIA, 6 minor stroke; mean age
69 years) consenting and completing the study. Mean time to enrolment from the TIA/stroke was 20.5 days.
Participants completed all assessment measures except VO2max testing, which all declined. The manual and telephone
contact were viewed positively, as credible sources of advice. Pedometers were valued highly, particularly for goal-
setting. Overall, 36 individual BCTs were used, the commonest being centred around setting goals and planning as
well as social support.
Conclusion: Recruitment and retention rates suggest that a trial to evaluate the effectiveness of a novel home-based CR
programme, implemented within 4 weeks of a first TIA/minor stroke is feasible. The commonest BCTs used within the
manual revolve around goals, planning and social support, in keeping with UK national guidelines. The findings from this
feasibility work have been used to further refine the next stage of the intervention’s development, a pilot study.
Trial registration: ClinicalTrials.gov Identifier: NCT02712385. This study was registered prospectively on 18/03/2016.
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Background
Strokes and transient ischaemic attacks (TIAs) are highly
prevalent conditions [1, 2] and the 90 day risk of vascu-
lar events following a TIA or ‘minor’ stroke can be as
high as 18% [3]. Therefore, the immediate period after a
TIA and ‘minor’ stroke is a crucial time to intervene to
reduce the risk of future strokes and the impact that
these conditions have on society.
Evidence is growing regarding the contribution of
change in modifiable risk factors to reductions in cardio-
vascular deaths [4] and there is a need to consider how
to promote non-pharmacological measures within sec-
ondary prevention [5]. Despite the knowledge surround-
ing vascular risk factors and the recognition that TIA/
‘minor’ strokes carry a significant morbidity and are
often the precursors of disabling strokes, stroke remains
the leading cause of adult disability [6].
Cardio- and cerebro-vascular disease share common
underlying pathological mechanisms and risk factors,
but cardiac rehabilitation for secondary prevention is
only offered to patients in the UK with cardiovascular
disease [7] and further research has been highlighted as
required in assessing the impact of lifestyle interventions
post-stroke and TIA [8]. The benefit of cardiac rehabili-
tation for secondary cardiovascular prevention is well-
evidenced. Indeed a systematic review of exercise-based
cardiac rehabilitation after a myocardial infarction (MI)
found statistically significant reductions in re-infarction
(odds ratio 0.53), cardiac mortality (odds ratio 0.64), and
all-cause mortality (odds ratio 0.74) [9]. More recently,
Rauch et al.’s review [10] has confirmed the benefits of
cardiac rehabilitation for mortality despite recent
advances in medical and surgical treatments.
Lennon et al. [11] and McKay-Lyons et al. [12] have
described randomised trials of community-based cardiac
rehabilitation programmes in both TIA and stroke
patients. These studies did not review the use of home-
based programmes, which we know are at least as effective
as community-based options whilst being more cost-
effective [13], and did not include a pedometer arm. These
studies finished early, with no results available in their clin-
ical trials registry entries or published. Both described a
relatively long-period from the event to entry into the trial
(up to 90 days for both studies). However other research
has shown that vascular risk factors should be addressed as
quickly as possible following the initial vascular event [14].
Prior et al. [15] have described a pilot study of a
community-based cardiac rehabilitation in 100 post-TIA
and ‘mild’ stroke subjects and showed important reduc-
tions in biological markers linked to cardiovascular and
cerebrovascular mortality. Thus community-based car-
diac rehabilitation programmes appear feasible in this
patient group. However the study did not include a con-
trol group, patients were eligible for inclusion up to
1 year post-event, the researchers did not offer home-
based rehabilitation and did not include pedometers in
the rehabilitation programme. Other authors have also
piloted community-based cardiac rehabilitation pro-
grammes in the TIA and minor stroke population, with
patients eligible for inclusion up to 1 year post-event
[16, 17] but no authors have previously assessed the
feasibility of adapting a home-based cardiac rehabilita-
tion programme, with or without an added pedometer
intervention, for use within this patient population in
the sub-acute period following diagnosis.
Compliance as well as uptake [18], particularly among
women and the elderly [19], with cardiac rehabilitation pro-
grammes is an issue, which can be improved through
home-based options. Cochrane Reviews have demonstrated
that home-based cardiac rehabilitation programmes can
result in similar health gains to hospital-based [20], or
centre-based programmes [13], with home-based pro-
grammes improving adherence to the programme [21].
Moreover, home-based cardiac programmes have shown
longer term sustainability of health benefits compared with
hospital-based programmes [22].
Physical inactivity is one of the most important recog-
nised risk factors for cerebrovascular disease [23] and
pedometers have been shown to be effective in promoting
physical activity [24] through different behaviour change
methods, including goal setting, providing feedback, and
monitoring of activity levels [25, 26]. Pedometers appear
feasible for use by patients with stroke [27, 28] and also
promote walking, which is one of the commonest forms
of physical activity for older adults to engage in [29]. A
systematic review on the role of exercise post-stroke has
however highlighted the lack of studies of pedometers in
the acute and sub-acute periods of TIA or stroke [30].
Pedometers also appear to promote physical activity in the
long-term, with De Cocker et al. showing that after 4 years
of follow-up, the pedometer intervention group had
higher physical activity levels than the control group [31].
Comprehensive programmes, which try to alter partici-
pants’ behaviours, are complex: information about their
‘active’ ingredients, such as specific BCTs [32], would
facilitate their replication and the implementation of
guidelines for good clinical practice [33, 34]. Identifying
behaviour change techniques (BCTs) used in different
behaviour change programmes has also been identified as
a national research priority [34]. Thus ‘The Healthy Brain
Rehabilitation Manual’, adapted from the ‘Heart Manual’,
the only validated home-based cardiac rehabilitation
programme supported by the UK National Institute for
Health and Clinical Excellence (NICE) for patients who
have had a myocardial infarction (MI) [35], is being
developed following the MRC guidelines for developing
complex health service interventions [36], to maximise
secondary prevention post-TIA and minor stroke.
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Research aims
The aim of this study is to assess the feasibility of evalu-
ating the effectiveness of a novel adapted home-based
cardiac rehabilitation programme, ‘The Healthy Brain
Rehabilitation Manual’, with or without a pedometer
intervention, initiated within 4 weeks of a first TIA or
minor stroke of atherosclerotic origin. We aimed to
assess rates of recruitment, completion of outcome
measures and follow-up, to explore participants’ views of
the programme and research methods, and to identify
the BCTs used within the programme.
Methods
Trial registration and ethics approval
The study was approved by the Office for Research Eth-
ics Committees, Northern Ireland (REC reference [15]/
NI/0001, 21/09/2015) and registered (ClinicalTrials.gov,
NCT02712385). We have followed CONSORT guide-
lines for reporting randomised feasibility trials [37] as
well as National Institute of Health Research (NIHR)
guidance for feasibility studies [38].
Study setting and participants
Patients attending TIA/ ‘minor’ stroke assessment hos-
pital clinics in Belfast (UK) were given information
about the study by a nurse and asked for their consent
to be telephoned by the lead researcher (NH) the follow-
ing day to invite their participation. Those who agreed
attended the Northern Ireland Clinical Research Facility
(NICRF), Belfast City Hospital, for an initial meeting
where, with consent, baseline data were collected.
Patients were eligible for inclusion if they were aged
18 years or older and within 4 weeks of their first symp-
toms of a TIA or ‘mild’ stroke. The diagnosis was made by
the consultant at the clinic, based on history, neurological
examination and neuroimaging [39]. Using the TOAST
classification system [40, 41] only TIAs and ‘minor’
strokes attributed to atherosclerosis or small vessel occlu-
sion were included. We excluded patients who had
unstable cardiac conditions or contra-indications for exer-
cise training [42] by screening patients using the Physical
Activity Readiness Questionnaire (PAR-Q) [43]. We also
excluded patients who were unable to give informed
consent or had a previous cerebrovascular event.
Data collection
At their initial meeting, lasting approximately 1 h, the
researcher measured height and weight (in light clothing,
using a Seca scale, model 799), waist circumference (as per
[44]), resting blood pressure and heart rate (using BpTRU,
model BPM-200 [45]), checked the heart rhythm manually
to exclude any dysrhythmias (radial pulse for 1 min) and
recorded other variables including sex, age, marital status,
smoking status, alcohol intake (units in a typical week
before diagnosis), time from initial event to study enrol-
ment, level of education (high school, apprenticeship,
further education college or University) and current
employment. A measure of deprivation (multiple
deprivation measure (MDM)) was derived from their
postcode [46]. We enquired about family history of cardio-
vascular disease (CVD), assessed physical activity levels
(validated International Physical Activity Questionnaire
(IPAQ) questionnaire [47, 48]) and calculated a Mediterra-
nean Diet Score using a validated questionnaire [49]. A 2-
min walk test was performed twice, separated by a rest
period of at least 30 min, and the average distance walked
in metres was calculated [50]. During the 2 min of testing
participants were encouraged to walk as fast and as far as
they could. A Hospital Anxiety and Depression (HADs)
questionnaire [51] was used to assess anxiety and depres-
sion, a EQ5D-5 L questionnaire (http://www.euroqol.org/
eq-5d-products/eq-5d-5l.html) to assess quality of life, a
Modified Rankin scale [52] to assess level of disability and a
Prochaska stages of change questionnaire relating to
physical activity was administered [53]. All participants
were offered VO2max exercise testing via either a treadmill
or bike.
The intervention – ‘The Healthy Brain Rehabilitation Manual’
The development of a novel home-based rehabilitation
programme for a TIA/‘minor’ stroke population followed
the Medical Research Council (MRC) guidelines for
developing complex health service interventions [36, 54].
In terms of programme content, ‘The Healthy Brain
Rehabilitation Manual’ contained an introduction, telling
the user how to use the manual, medical and social
information about TIAs/‘minor’ strokes and how to set
goals and action plans for changing certain aspects of
their lives. There was then sections focusing on topics
relevant to cardiovascular risk (smoking, physical and
sexual activity, mental health issues (primarily anxiety
and depression), community resources (e.g. smoking
cessation support; exercise classes), diet and secondary
prevention medication). The manual was supported with
telephone follow-up by a health professional, a General
Practitioner (GP). Participants were given advice about
how to know that they were participating in moderate
intensity activity. Those with a pedometer were advised
that a cadence of 100 steps/min corresponds to moder-
ate physical activity and for those who did not have a
pedometer, they could use the ‘talk/sing test’ [55]. This
was explained to patients at their baseline assessments
and was included in the manual as well as being
reinforced through the telephone follow-up.
Two trained review authors (NH, MAT) independently
assessed the manual to identify BCTs included, using
Michie’s BCT taxonomy [32] of 93 hierarchically clus-
tered techniques and a narrative approach was used to
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describe the use of BCTs within the rehabilitation
programme. They met to discuss the BCTs which they
had identified and resolve any discrepancies. A third
reviewer (FK) was available to arbitrate in case consen-
sus could not be reached, but was not required.
Randomisation and blinding
Computer generated randomisation was carried out prior
to recruitment and the allocations were concealed in sealed,
opaque envelopes until baseline assessments were
completed. Post-intervention assessments were undertaken
by NH, who was not blinded to intervention allocation.
Study design
There were 3 study arms: the control group, Group 1,
received current standard post-TIA/minor stroke care as
per current UK guidelines [35, 56]. In addition to stand-
ard care, Groups 2 and 3 received the intervention
programme (‘The Healthy Brain Rehabilitation Manual’).
Group 3 also received a pedometer or a Fitbit Charge,
with each participant choosing which they wanted to
use, and being encouraged to keep a daily step-count
diary. NH advised Groups 2 and 3 regarding the use of
the manual and pedometer/diary at the end of their
initial meeting and assessment. Participants in Groups 2
and 3 were informed about the national UK physical
activity guidelines as well as how to achieve moderate
and vigorous physical activity intensity [57]. The pedom-
eter was used to allow participants to set and monitor
goals to increase their physical activity levels.
All participants, including Group 1, were telephoned at
1 and 4 weeks to answer any questions regarding their
care or use of the manual and, for Group 3, NH encour-
aged participants to self-set step count targets after
reviewing the previous week’s daily step counts [24]. Step
counts were recorded, as reported by participants at the
end of week 1 and diary records were reviewed by NH at
the 6-week follow-up. Average step-counts for weeks 1
and 6 were calculated by adding the daily totals and divid-
ing by the number of days/week worn by the participant.
During the initial meeting and telephone contacts NH
used motivational interviewing techniques [58], guided by
the theory of planned behaviour [59] and adopting the ‘5
As’ approach to behaviour change [58], which have all
been utilised within different healthcare settings [60],
including primary care and the community.
Data treatment and statistical analysis
No formal power calculation was undertaken as this was a
feasibility study but 5 patients in each of 3 treatment groups
was considered sufficient to allow assessment of the feasi-
bility of recruitment, conduct of proposed assessments and
retention. It was also considered that 15 patients’ views
could provide useful information regarding our research
methods and the acceptability of the intervention
programme and its refinement for potential use in a pilot
trial. Descriptive statistics were reported for baseline and
post-intervention measurements, using Statistical Package
for Social Sciences (SPSS, version 23) but the main out-
comes were rates of recruitment, retention and completion
of measures and the acceptability of the intervention.
Qualitative work
All participants were invited to attend a focus group
which took place at least 2 months after their comple-
tion of the study and they were encouraged to bring
their partner or a family member to the focus group.
The primary questions of the topic guide (Appendix)
related to research participation and the acceptability of
the different stages of the research study [61]. The focus
group discussion was led by NH, audio-recorded with
the consent of participants, lasted approximately 1 h and
was transcribed by NH. Content analysis was undertaken
with the practical purpose of eliciting views about the
acceptability and usability of the intervention and
research methods and how these could be refined. NH, a
male GP, and MD, a male health services researcher/
health psychologist, read and reread the transcripts and
coded the content independently. NH and MD met to
discuss the main areas covered within the transcripts.
MC, a female professor of GP, acted as a referee as
required as well as appraising critically the categories
and the degree to which the transcript extracts and quo-
tations supported the themes. The transcripts were not
returned to participants for comment and/or correction
and participants were not asked to provide feedback on
the qualitative results. NH has basic training in qualita-
tive research methods whilst MD and MC are experi-
enced qualitative researchers. The independent results of
the qualitative analysis and data interpretation were
discussed with the entire research team, to ensure clear
definition of themes and that appropriate supporting
evidence was identified for each. The reporting of the
qualitative study and findings followed the guidance set
out in the Consolidated Criteria for Reporting Qualita-
tive Research (COREQ) checklist [62].
Results
Recruitment, retention and completion of assessment
measures
During an 18-week recruitment period (March to July,
2016) 107 patients with confirmed TIA/minor stroke
attended the hospital TIA clinic. From the hospital data
recorded, we were unable to determine how many of these
were eligible for the study but 28 eligible patients (15
male; 13 female) agreed to telephone contact from NH.
Of these, 15 (10 male; 5 female; 53.6%) consented to
participate. All of these completed the study and attended
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for 6-week follow up assessment. Participants completed
all the outcome measures apart from the maximal exercise
tests for VO2max assessment, which was declined by all
participants at baseline and follow-up. Four participants in
Group 3chose to use a Fitbit Charge initially as their
pedometer; 2 reported positive experiences using this
device, particularly in goal setting and competition with
other users but 2 others were unable to use it and trans-
ferred to use a pedometer, Yamax Digi-Walker CW-701,
with which no patients reported any problems.
Baseline characteristics
The participants’ mean age was 69 years; 9 were diagnosed
with a TIA and 6 a minor stroke (Table 1). Mean time
from event to enrolment was 20.5 days. Only one had
attained University level education; most had retired. The
majority [10] lived in the 50% least disadvantaged areas of
Northern Ireland. Although 7 were ex-smokers, only one
participant currently smoked; mean alcohol intake was
<14 units/week. Ten participants had a first degree relative
with CVD and most participants were married (13/15).
Baseline IPAQ scores indicated that 10 were either
inactive or minimally active and many (9/15) reported
sitting for over 5 h daily. In their first week, Group 3
participants averaged over 8000 steps/day. Baseline mean
systolic and diastolic blood pressure (SBP and DBP) were
<140/90 mmHg in all groups. The total HADs score was
elevated in all 3 groups, particularly for anxiety symptoms.
Most participants within the study were classed as
‘overweight’ as per their BMI.
Post-intervention assessment
Groups 3’s mean daily step counts increased over the
6 weeks of the intervention by 1407, with a concomitant
fall in the numbers in the IPAQ categories of ‘inactive’
and ‘minimally active’ (Table 2). Participants reported
Table 1 Baseline characteristics of participants
Group 1 (Control) Group 2 (Manual) Group 3 (Manual + pedometer)
Number of patients 5 5 5
Sex (M – male, F – female) 4 M 1F 4 M 1F 2 M 3F
Diagnosis 1 TIA 4 TIA 4 TIA
4 Minor stroke 1 Minor stroke 1 Minor stroke
Mean age (years) 76.2 67.8 63
Mean time (days) event to enrolment
(Standard Deviation (SD))
19.8 (SD 7.09) 22.2 (SD 9.18) 19.6 (3.58)
Level of education 3 High school 3 High school 1 High school
2 Further Education College 2 Further Education College 3 Further Education College
1 University
Employment 1 Employed 2 Employed 1 Employed
4 Retired 1 Unemployed 4 Retired
2 Retired
Multiple deprivation measure (MDM) median (range)a 784 (51–863) 413 (250–726) 681 (333–825)
Family history of cardiovascular disease
(<55 years for males, <65 years old for females)
4 3 3
Marital status 1 Single 5 Married 4 Married
4 Married 1 Divorced
Smoking status 2 non-smokers 2 non-smokers 3 non-smokers
3 ex-smokers 2 ex-smokers 2 ex-smokers
1 current smoker
Modified Rankin scale
0 2 2 4
1 1 1 1
2 1 1 0
3 0 1 0
4 1 0 0
aMultiple deprivation measure (MDM) is calculated from the subject’s postcode and is a marker of spatial deprivation
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good compliance with the pedometer, wearing it on
most days, as recorded in the step-count diary. IPAQ
data for Group 2 also showed an increase in physical ac-
tivity and a reduction in hours sitting per day. The two-
minute walk distance increased in all groups, with the
greatest increase in Group 3. HADs scores, particularly
for anxiety, improved in Groups 2 and 3. There was a
wide variation in the rest of the measurements and over-
all they showed only small changes.
Qualitative findings
Seven research participants (3 male; 4 female) and one
partner (female) attended the focus group. Their ages
ranged from 55 to 82 years. Four participants were from
Group 3, 2 from Group 1 and 1 from Group 2. Qualitative
findings were analysed in order to determine participants’
views of the manual, the study design and changes needed
for a pilot study of the effectiveness of a novel home-
based programme for rehabilitation for patients with TIA
Table 2 Study Group Baseline and Post-Intervention Measurements (Mean (Standard Deviation (SD)) and categorical values)
Group 1
(Control) – baseline
Group 1 –
post-intervention
Group 2
(Manual) – baseline
Group 2 –
post-intervention
Group 3 (Manual +
pedometer) – baseline
Group 3 –
post-intervention
IPAQ category
Inactive 2 1 3 1 1 0
Minimally active 1 4 1 0 2 1
Health-enhancing
physical activity levels
2 0 1 4 2 4
IPAQ continuous score
(Mean (SD))
1514.6 (SD 1470.1) 1093.8 (SD 851.1) 870.4 (SD 948.2) 4366.2 (SD 3140.8) 1531.2 (SD 902.5) 5335.8 (SD 3133.6)
IPAQ number of hours
sitting/day
6.20 (SD 4.10) 6.3 (SD 4.0) 4.80 (SD 1.5) 3.2 (SD 1.3) 5.00 (SD 1.0) 3.8 (SD 1.3)
Steps/day 8356 9762.8 (SD 3473.5)
Stages of change for physical activity
1 1 1 1 0 0 0
2 0 0 3 0 1 0
3 2 2 0 1 1 0
4 0 0 0 3 2 4
5 2 2 1 1 1 1
Mediterranean diet
total score
5.6 (SD 3.1) 5.8 (SD 2.5) 6.2 (SD 3.3) 8.4 (SD 2.3) 6.0 (SD 2.2) 8.0 (SD 1.4)
Number of pieces of
vegetables/day
1.6 (SD 1.1) 1.8 (SD 1.5) 2.2 (SD 1.8) 2.4 (SD 0.6) 2.0 (SD 1.2) 2.8 (SD 0.8)
Number of pieces of
fruit/day
2.2 (SD 1.9) 2.6 (SD 1.5) 2.2 (SD 1.3) 2.8 (SD 1.3) 3.4 (SD 0.9) 4.0 (SD 1.4)
Systolic blood pressure
(mmHg)
135.8 (SD 8.4) 135.8 (SD 24.8) 136.2 (SD 15.2) 128 (SD 2.0) 129.4 (SD 15.2) 131.0 (SD 12.9)
Diastolic blood pressure
(mmHg)
76.4 (SD 10.8) 76.8 (SD 10.0) 82.8 (SD 13.9) 74.8 (SD 4.0) 77.2 (SD 8.1) 80.4 (11.2)
Resting heart rate
(beats per minute)
66.2 (SD 3.0) 71.6 (SD 8.4) 65.6 (SD 0.9) 74.8 (SD 4.0) 75.0 (SD 9.4) 73.8 (SD 10.8)
2 min walk test performance
(metres walked)
109.5 (SD 46.3) 118.2 (SD 28.2) 128.8 (SD 29.1) 149.8 (SD 28.7) 136.5 (SD 41.5) 163.4 (SD 23.4)
Weekly alcohol intake
(units/week)
6.4 (SD 12.1) 5.6 (SD 8.4) 5.6 (SD 10.4) 1.6 (SD 2.6) 2.8 (SD 3.0) 2.4 (SD 2.6)
HADs total score 10.6 (SD 6.5) 11.0 (SD 5.2) 10.4 (SD 4.7) 7.4 (SD 5.5) 7.00 (SD 4.2) 3.8 (SD 2.7)
HADs Anxiety score 6.0 (SD 4.1) 6.2 (SD 3.6) 6.0 (SD 2.1) 4.2 (SD 3.5) 5.2 (SD 2.8) 3.0 (SD 2.0)
HADs Depression score 4.6 (SD 3.2) 4.8 (SD 2.4) 4.4 (SD 3.1) 3.2 (SD 2.4) 1.8 (SD 1.9) 0.8 (SD 0.1)
EQ5D5L overall score 0.7 (SD 0.4) 0.7 (SD 0.4) 0.9 (SD 0.1) 1.0 (SD 0.1) 1.0 (SD 0.0) 1.0 (SD 0.1)
EQ5D5L VAS score 66.0 (SD 32.1) 53 (SD 29.7) 72.0 (SD 17.5) 86 (SD 6.5) 83.0 (SD 18.2) 85.8 (SD 17.6)
Weight (kg) 80.6 (SD 10.9) 80.3 (SD10.9) 80.7 (SD 8.1) 80.1 (SD 8.2) 79.6 (SD 15.6) 79.4 (SD 16.5)
BMI (kg/m2) 27.3 (SD 2.5) 27.2 (SD 2.5) 29.7 (SD 3.2) 29.5 (SD 3.4) 28.2 (SD 2.2) 28.1 (SD 2.2)
Waist circumference (cm) 97.7 (SD 5.7) 97.7 (SD 5.7) 99.9 (SD 6.1) 98.7 (SD 6.5) 101.2 (SD 11.3) 100.4 (SD 11.1)
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or minor stroke. The analysis, supported by anonymised
quotes (coded by age (years) and sex (M/F)), is reported
within three themes relating to the content of the data.
Use of the manual
All participants had positive views about the manual. Its
content provided reassurance and support, particularly in
differentiating between symptoms for which they should
seek medical help and those that were not of such signifi-
cance. Some reported how they referred to it after having
received varying information about their condition and
risk factors from different healthcare professionals.
“…there was some days when I was panicking a bit
and I got the book out and I was like, no, that
symptom is ok, that’s normal….” (F)
“I think this (the manual) should be at doctor (GP)
surgeries as well because when you go to speak to the
doctor you get conflicting advice at times.” (F)
Participants’ comments reflected their fear and uncer-
tainty about their future health, attributed to their
experience of sudden onset symptoms of their TIA or
minor stroke. Some appeared to be in denial of their
diagnosis, based on a rationale that their symptoms had
been mild (predominantly affecting vision and speech;
one had right-sided weakness) and transient but their
comments also reflected a sense of uncertainty. How-
ever, the manual was welcomed by all as a reference
source for credible information that helped them to
understand their diagnosis.
“It (the TIA) just frightened me and knocked my
confidence… because you get no warning.” (F)
“You know, for just 10 minutes’ worth of symptoms,
surely nothing serious could have happened?” (F)
“I thought it was excellent…….. like a bible” (M)
Family members also used the manual in supporting
decision-making about seeking medical help. Some did so
effectively but others were less helpful: one participant’s
comments indicated how her family members wished they
could deny the significance of her symptoms.
“…I was just going to go to my bed but my daughter
phoned and I said to her the symptoms I was having
and she took me straight to Accident and Emergency
(A&E) department.” (F)
“My daughters didn’t want to read it because if you
read it, then it’s true…” (F)
Other information in the manual provided reassurance for
those who felt guilty about not being able to fulfil their pre-
vious work-life commitments, particularly as they had no
visible physical manifestations of illness. Information re-
garding the relevance of healthy lifestyle behaviours in help-
ing to reduce risk of further events was valued and
participants reported having continued to access it after the
study programme had ended: some reported that they put
the manual in a prominent place to remind them to sustain
preventive behaviours. Other comments indicated how
family members used the manual to encourage mainten-
ance of healthy behaviours. Those who had received posi-
tive feedback about progress in reducing their risk factors
attributed this to having followed guidance in the manual.
“I felt an awful fraud cause I was off work but there
was nothing physically wrong with me…nothing to
show ” (F)
“I lift it every morning, read a wee bit, remind myself
why I’m not smoking, why I’m not eating a whole
load of pastries and why I’m avoiding salt….I might
just read a line but it’s the very fact that it’s sitting
there, reminding me of what to do right….I find that
very important…” (M)
“my grand-daughter has read it from page to page and
every time she comes up to see me, she’s like, ‘grandad,
have you done that? Are you keeping to that?” (M)
“The fact that my blood pressure is a lot lower is also
very encouraging for me to stay with the programme
as I feel the things which I have done have definitely
helped me…” (F).
The study design
Recruitment and randomisation None of the partici-
pants considered that any change was needed to the
process of recruitment or method of being allocated to
study groups.
Intervention components – telephone follow-up The
structure and timing of telephone follow-up calls were
well received by all participants who considered that they
reduced their need to seek other medical advice. Com-
ments revealed how participants valued the opportunity
to share concerns with a professional and ask questions.
For example, many participants expressed how they had
fears for the implications of their diagnosis on future
travel plans and being able to obtain travel insurance
“………they made me feel that there was someone out
there interested in me and who cares for me.” (M)
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“...it put your mind at rest because you were thinking,
NH is phoning me soon, so I don’t need to go to see
the GP. I enjoyed the explanations.” (F)
“…..are we going to get to go on holiday and will I be
able to fly?” (F)
Intervention components - pedometers
All Group 3 participants enjoyed using their pedome-
ters, setting step-count targets and competing with
others regarding their achievement of these. One partici-
pant reported her appreciation of the Fitbit with its
provision of weekly email feedback on her performance.
However, two participants discontinued using the Fitbit
despite research team support, one because of battery
problems and one lacked confidence in its accuracy:
both used the Yamax pedometer without difficulty.
“…it’s a competition between me and the wife who
walks the furthest” (M)
“ It was just so addictive …. I had that visual target to
aim for…It would also send me an email at the end of
the week, telling me how much activity I had done
and I just thought it was brilliant.” (F)
“…and the pedometer would always be less (in step-
count measurement compared to Fitbit)….” (F)
Outcome assessments
All participants were also content with the number
and duration of assessments and with all outcome mea-
sures except treadmill exercise testing. They were appre-
hensive that they would be unable to complete it, given
their recent diagnosis. However, 4 participants expressed
a readiness to consider undertaking it at the time of the
focus group, approximately 2 months after having com-
pleted the rehabilitation programme.
“I doubt that I would have been able to do the
treadmill exercise test within 4 weeks of having the
TIA….” (M)
“I would be interested in doing it now…” (Two Fs)
Suggested changes
The only changes suggested by study participants related
to the manual. One suggestion was to move the explana-
tions about TIA and minor stroke to the beginning of
the manual and another was to include a patient’s story.
“…. the explanation for the TIA (and minor stroke) is
at the back of the manual. I think it should be at the
start?’” (F)
“people are interesting and it’s good to hear their
experiences…” (F)
BCTs used within the manual
Overall, 36 individual BCTs, from 14 different BCT groups
were utilised. Examples of how the BCTs were used in
each section of the manual are included in Additional file 1:
Tables S1 to S8. Within Section 1 (Smoking) 16 individual
BCTs were used and in section 2, dealing with physical/
sexual activity, with 11 being used in total. The common-
est BCTs used were “1.1 Goal setting (behaviour)”, “3.1
Social Support (unspecified)” and “3.3 Social support
(emotional)” – all being used within 5 of the 8 manual
sections. The commonest groups of BCTs used within the
manual were “1 (Goals and Planning)”, being detected 18
times and Social Support (12 times). Two groups of BCTs
were not used within the manual, “14 (Scheduled conse-
quences)” and “16 (Covert learning)”.
Discussion
These findings indicate that the evaluation of a novel
home-based rehabilitation programme, ‘The Healthy
Brain Rehabilitation Manual’, implemented within
4 weeks of a first TIA or ‘minor’ stroke is feasible. There
was 100% retention of participants and more than 50%
of patients who were invited by the researcher agreed to
participate, although we could not be certain that all
eligible patients consented to allow contact by the
researcher. All but one of the proposed assessments, the
VO2max testing, were fully completed at baseline and
follow-up. This study also illustrates the acceptability of
pedometers as an appropriate method of promoting
physical activity to generally inactive TIA and minor
stroke patients. The rehabilitation programme was
centred on the use of ‘goals and planning’ and social
support as BCTs as well as the manual being a credible
source of information to promote behaviour change. A
Logic Model has been developed for this feasibility study
and is included in Fig. 1 [63, 64].
Comparison with previous literature
In comparison with previous studies of community-
based cardiac rehabilitation for patients with TIA or
‘mild’ stroke, we have achieved higher rates of recruit-
ment (50% of those invited) and retention (100%). A
feasibility study [17] reported 62% retention of 85
patients enrolled and, in a pilot study [15], approxi-
mately 50% of 100 invited patients consented to partici-
pate and roughly 80% completed the study. Of note,
home-based cardiac rehabilitation programmes are
reported to improve programme adherence [21] and to
show longer-term sustainability of health benefits
compared with hospital-based programmes [22].
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An interesting finding was that all participants
declined to undertake a maximal VO2 test, both pre-
and post-intervention, whereas all other assessments
were well received. To our knowledge, this is the first
study to report this finding. Exercise testing is safe to
undertake among patients with TIA and stroke [65] as
well as generally within the elderly population [66] but
our participants felt unable to complete it. Thus, for
further work, we have omitted the maximal exercise test,
adding the Timed Up and Go test [67] and accelerom-
eter assessments of physical activity pre- and post-
intervention, which are reliable objective measures of
physical activity in stroke survivors [68] and amongst
the elderly population [69]. However, the Timed Up and
Go test is a short test of physical performance which can
be insufficient to capture deficiencies in cardiovascular
endurance. Thus, we plan also to use accelerometry to
assess participants’ physical activity levels, as well as to
measure gait speed during the 2-min walk tests as this
has been shown to be an important predictor of morbid-
ity and mortality in the elderly population [70].
The Group 3 participants increased their physical
activity by 1400 steps/day over the study period of
6 weeks. Indeed, walking ability has been demonstrated
to be strongly associated with cardiorespiratory fitness
[71] as well as being helpful in guiding prognosis in
patients with cardiovascular disease [72]. Moreover, an
increase in steps/day walked after cardiac rehabilitation
has been shown to reduce overall risk of mortality and
hospitalization [72] Therefore the improvement in phys-
ical activity levels (steps/day) demonstrated within this
feasibility study could contribute to making our TIA and
‘minor’ stroke patients live longer as well as healthier
lives. Previous studies have also shown that there is
potential for larger increases to be achieved with pedom-
eter interventions [26, 73–75], with potential to reduce
Fig. 1 Intervention logic model
Heron et al. BMC Cardiovascular Disorders  (2017) 17:290 Page 9 of 14
cardiovascular risk factors further, particularly amongst
those who are the least active. It has been suggested that
healthcare workers should enquire regularly about the
walking status of their patients and that this should be
viewed as an another ‘vital sign’ in healthcare [76].
Pedometers are also accurate and reliable in measuring
ambulatory activity [75, 77–79] whilst also being rela-
tively inexpensive. Yamax pedometers have been shown
to be the most accurate waist-borne instrument [75, 77].
The intervention appeared to improve quality of life as
measured by the EQ-5D-5 L VAS scale and mental
health, as measured by the HADs questionnaire [51],
although numbers were small and no significance testing
was carried out. In keeping with previous work [80]
which found a prevalence within TIA survivors of
anxiety symptoms of up to 30% and depression symp-
toms of up to 21%, our focus group participants were
anxious and fearful about having future events. Patients
appreciated the explanations and reassurance provided
by the manual.
It is important for complex health service interven-
tions to be evidence-based and to know that they are
not only effective but how and why they are effective
[81]. Specifying and describing how a programme of
behaviour change actually works is also advocated by
UK national guidelines [34], with journal editors
requesting detailed descriptions of the active interven-
tion within their reporting guidelines [82]. Thus, the
active ingredients within a programme should be identi-
fied [83]. NICE [34] have advocated the use of BCTs
which have been proven to be effective in promoting
behaviour change, particularly ‘goals and planning’;
‘feedback and monitoring’; and, ‘social support’. ‘The
Healthy Brain Rehabilitation Manual’ includes goal-setting
for behaviour change, with agreed action plans and relapse
prevention (‘if-then’) plans for each behavioural cardiovas-
cular risk factor. These goals and plans are reviewed and
refined in follow-up contacts with the health professional/
facilitator. The manual includes feedback and monitoring
as a BCT, for example, based on review of pedometer step
counts. Social support is promoted through contact with
health professionals and encouraging the person to share
the manual with their family and friends and get them to
join in the behaviour change.
Strengths and limitations
This is a feasibility study and therefore no statistical
analysis was undertaken on the outcomes. Baseline
assessments were completed before participants were
allocated to different groups, to avoid allocation bias.
The qualitative work undertaken included participants
from each treatment group, of varying age and both
sexes, with a range of different symptoms and experi-
ences and they identified valued components of the
rehabilitation programme. The educational attainment of
our participants was less than third level (post secondary
school education), with only one having a University degree
and no one reported any difficulty in following guidance or
understanding information within the manual. This was
reassuring since, in developing it, we had performed a read-
ability check (http://www.webpagefx.com/tools/read-able/
check.php), showing it to be readily understandable to 13
to 14 year olds.
The pragmatic approach, whereby TIA and ‘minor’
stroke diagnosis was made by the lead clinician at each
clinic, may have led to variation in the case mix due to
differing interpretation of clinical data but this was
accepted as a reflection of ‘real-world’ practice. There
was no post-intervention blinding of assessments so that
it is possible that some measurement bias may have
occurred. Also, Group 3 participants were not blinded to
their step counts in the first week of the study, so that
the baseline measure may be inflated and not a true
reflection of levels of physical activity at this time in TIA
and minor stroke patients.
Whilst initial discussions with clinical staff regarding the
process of identification and invitation of eligible patients
had included a plan to record anonymously the numbers
of all eligible patients, this information was not recorded.
Thus, although data suggested that 79 of the 107 clinic
attendees during the recruitment period were ineligible,
this could not be confirmed and limits our interpretation
of the feasibility and acceptability of the research.
A strength of our study is the careful approach we have
taken to identifying the ‘active ingredients’ of the interven-
tion. However, we recognise that our focus was on the
manual content and that other BCTs were also involved in
the delivery of the programme, during telephone contacts.
No monitoring of the fidelity of these contacts was under-
taken but this could be achieved in further study.
Implications for future work
In planning further development and evaluation of the
intervention, ‘The Healthy Brain Rehabilitation Manual’
we will conduct a pilot study, involving other hospital
clinics and ensuring that information is recorded
regarding all eligible patients. In setting step-count
goals for physical activity, only Yamax Digi-Walker
CW-701 pedometers will be used. We will discard the
maximal VO2max exercise test and instead use the
Timed Up and Go test [67] pre- and post-intervention,
with accelerometer assessments, which provide reliable
objective measures of physical activity in stroke survi-
vors [68] and older people [69]. We will also include a
‘patient story’ in the ‘The Healthy Brain Rehabilitation
Manual’, in-keeping with previous authors’ work [84],
and will place information about TIAs and strokes at
the start of the manual.
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Conclusion
Our findings show the feasibility, acceptability and
potential significance of implementing, early after
TIA or ‘minor’ stroke, a novel home-based
programme, ‘The Healthy Brain Rehabilitation Man-
ual’, with or without an added pedometer. The main
BCTs utilised within the manual included use of a
credible source, social support and goal setting, in
keeping with current UK national guidance for be-
haviour change. This preliminary work has informed
the design of a pilot study which is in progress, with
longer follow-up, recruitment from a range of set-
tings and refined methodology (clinicaltrials.gov
(NCT02712385)). This future work should provide
evidence of the value of early intervention that is
focused on behaviour change for patients following
TIA or minor stroke.
Appendix
Focus group topic guide
Impact of the diagnosis/illness on the patient:
1) After the diagnosis, what was your biggest problem,
e.g. fatigue?
2) How did the diagnosis affect your life?
Views on the manual:
3) What do you think of the manual?
4) What do you think about the general level of
information included within the booklet – too
much/too little?
5) What do you think of the length of the booklet? Is it
too short? Is it too long?
6) What do you think of the layout of the booklet?
Does it need more colour, pictures, different font
size, etc.?
7) Would you like a patient story within the book –
detailing their thoughts/emotions after being
diagnosed with a TIA/minor stroke?
8) Are there any risk factors which haven’t been
covered, which you would like included? Are there
any risk factors on which you would like more
information to be given – or less?
9) Did family members read the manual? What did
they think? Anything which you particularly enjoyed
about the manual?
10)Anything you would improve about the manual?
Exercise programme within the manual:
11)Is there anything in particular which would worry
you about exercising or asking people to exercise
after a TIA/stroke?
12)What do you think of the exercise programme?
Would you be able to do this within your own
home? Is it hard enough?
Study duration and future goals:
13)What goals/aims are important to you now that you
have been diagnosed and are on the path to
recovery?
14)What did you think about the duration of the study
follow-up? Longer/shorter?
Review of FitBit v pedometer:
15)What are your views on the pedometer?
16)How did people find using the FitBit compared to
the pedometer? What did you prefer/ why?
17)What made you stop using the FitBit?
Research assessments and exercise treadmill test:
18)What did people think about how they were invited
and then recruited into the research study?
19)What did people think about the research
assessments?
20)What did people think about the amount of time
involved in the research assessments?
21)Why did people refuse to consent to the treadmill/
bicycle exercise test?
Additional file
Additional file 1: Table S1. BCTs utilised within the Manual Preface.
BCTs used within the Manual’s preface. Table S2. BCTs utilised within the
Manual Introduction. BCTs used within the Manual’s Introduction. Table
S3. BCTs utilised within Section 1 – Smoking. BCTs used within section 1
of the manual. Table S4. BCTs utilised within Section 2 – Physical
Activity. BCTs used within section 2 of the manual. Table S5. BCTs
utilised within Section 3 – Healthy Eating and Alcohol. BCTs used within
section 3 of the manual. Table S6. BCTs utilised within Section 4 – Stress
and Fatigue. BCTs used within section 4 of the manual. Table S7. BCTs
utilised within Section 5 - Medication. BCTs used within section 5 of the
manual. Table S8. BCTs utilised within Section 6 – Community Support.
BCTs used within section 6 of the manual. (DOC 197 kb)
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